• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养的正常人二倍体成纤维细胞衰老过程中的核糖核苷酸还原酶活性。

Ribonucleotide reductase activity during the senescence of normal human diploid fibroblasts in culture.

作者信息

Dick J E, Wright J A

出版信息

Mech Ageing Dev. 1985 Oct 14;32(1):85-97. doi: 10.1016/0047-6374(85)90038-7.

DOI:10.1016/0047-6374(85)90038-7
PMID:3915049
Abstract

Changes in ribonucleotide reductase occur during the senescence of normal human diploid fibroblasts in culture. Enzyme activity is significantly lower in cells and extracts at high mean population doublings (MPD) as compared to fibroblasts at low MPD. Although many of the kinetic properties of the enzyme remain unaltered in cells at high MPD, changes in the extent and kinetic mechanism of inhibition of CDP and ADP reductase activity by dATP, the overall negative effector of ribonucleotide reductase, were observed. These results and a previous observation that the four deoxyribonucleotide pools are markedly altered during in vitro senescence of human diploid fibroblasts, provide evidence for a link between ribonucleotide reduction, deoxyribonucleotide pools, and the establishment of the non-proliferative or senescent state.

摘要

在培养的正常人二倍体成纤维细胞衰老过程中,核糖核苷酸还原酶会发生变化。与低平均群体倍增数(MPD)的成纤维细胞相比,高MPD的细胞和提取物中的酶活性显著降低。尽管该酶的许多动力学特性在高MPD的细胞中保持不变,但观察到核糖核苷酸还原酶的总体负效应物dATP对CDP和ADP还原酶活性的抑制程度和动力学机制发生了变化。这些结果以及先前的一项观察结果,即人类二倍体成纤维细胞在体外衰老过程中四个脱氧核糖核苷酸池会发生显著改变,为核糖核苷酸还原、脱氧核糖核苷酸池与非增殖或衰老状态的建立之间的联系提供了证据。

相似文献

1
Ribonucleotide reductase activity during the senescence of normal human diploid fibroblasts in culture.培养的正常人二倍体成纤维细胞衰老过程中的核糖核苷酸还原酶活性。
Mech Ageing Dev. 1985 Oct 14;32(1):85-97. doi: 10.1016/0047-6374(85)90038-7.
2
Human diploid fibroblasts with alterations in ribonucleotide reductase activity, deoxyribonucleotide pools and in vitro lifespan.核糖核苷酸还原酶活性、脱氧核苷酸池及体外寿命发生改变的人二倍体成纤维细胞。
Mech Ageing Dev. 1984 Jul;26(1):37-49. doi: 10.1016/0047-6374(84)90163-5.
3
Involvement of ribonucleotide reductase activity in the senescence of normal human diploid fibroblasts.核糖核苷酸还原酶活性与正常人二倍体成纤维细胞衰老的关系。
Mech Ageing Dev. 1982 Oct;20(2):103-9. doi: 10.1016/0047-6374(82)90062-8.
4
Ribonucleotide reduction in intact human diploid fibroblasts.完整人类二倍体成纤维细胞中的核糖核苷酸还原
J Cell Physiol. 1980 Oct;105(1):63-72. doi: 10.1002/jcp.1041050109.
5
On the importance of deoxyribonucleotide pools in the senescence of cultured human diploid fibroblasts.论脱氧核糖核苷酸库在培养的人二倍体成纤维细胞衰老中的重要性。
FEBS Lett. 1985 Jan 1;179(1):21-4. doi: 10.1016/0014-5793(85)80182-4.
6
Deoxyribonucleotide pools in mouse-fibroblast cell lines with altered ribonucleotide reductase.核糖核苷酸还原酶改变的小鼠成纤维细胞系中的脱氧核糖核苷酸池
Eur J Biochem. 1976 Dec;71(1):39-43. doi: 10.1111/j.1432-1033.1976.tb11087.x.
7
Independent fluctuations of cytidine and adenosine diphosphate reductase activities in cultured Chinese hamster fibroblasts.培养的中国仓鼠成纤维细胞中胞苷二磷酸还原酶和腺苷二磷酸还原酶活性的独立波动
Biochim Biophys Acta. 1976 Apr 15;432(1):80-91. doi: 10.1016/0005-2787(76)90043-5.
8
Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase.p53R2 是核糖核苷酸还原酶的一个亚基,具有错义突变的人成纤维细胞在有丝分裂和静止期的脱氧核苷酸代谢。
J Biol Chem. 2011 Apr 1;286(13):11132-40. doi: 10.1074/jbc.M110.202283. Epub 2011 Feb 5.
9
Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.耐膦甲酸的突变型S49 T淋巴瘤细胞系的筛选与鉴定:核糖核苷酸还原酶受抑制的证据
J Cell Physiol. 1986 May;127(2):281-7. doi: 10.1002/jcp.1041270214.
10
Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductase.核苷5'-三磷酸类似物作为哺乳动物核糖核苷酸还原酶的正负效应物。
Cancer Biochem Biophys. 1985 Jun;8(1):23-8.